Premium Dr Agarwal’s Healthcare IPO Day 3 Highlights: Dr Agarwal IPO opened for subscription on Wednesday, January 29, and will close on Friday, January 31. Dr Agarwal’s Healthcare IPO Day 3 H ...

Assigning a 'subscribe' tag to the public issue, Anand Rathi says, "At the upper band, the company is valued at 134x its FY24 EPS. Following the issuance of equity shares, the company's market ...

While the actor has been receiving immense love and fame for his roles as an antagonist, he will once again be seen in a similar avatar in Hari Hara Veera Mallu which will revolve around Mallu’s ...

The initial public offer of Dr Agarwal's Health Care saw a muted response on the first day of bidding (January 29). The IPO received bids for 38.09 lakh shares, as against the offer of 5.35 crore ...

The initial public offering (IPO) of Dr Agarwal's Health Care continued to attract a muted response from the investors during the second day of the bidding process as QIB and HNI bidders ...

The initial public offer of Dr Agarwal's Health Care continued to see a muted response on the second day of bidding (January 30). The IPO received bids for 2.26 crore shares, as against the offer ...

Dr Agarwal Healthcare IPO opens January 29 at ₹382-402 per share. GMP trends lower at ₹15, signaling a 4% premium. High OFS component dampens growth prospects for the ₹3,027 crore issue. ETMarkets.com ...

Dr. Agarwal's Healthcare IPO opened for subscription with a 6% subscription on day one. The issue, valued at Rs 3,027 crore, has a 9% subscription in the retail portion and 4% in the non-institutional ...

Pawan Kalyan's Hari Hara Veera Mallu is one of the most highly anticipated films of 2025. On the occasion of Bobby Deol's birthday, the makers released the first-look poster of his antagonist ...

On Bobby Deol's birthday, Hari Hara Veera Mallu makers unveiled his character poster. Take a look at it here. On the occasion of Bobby Deol's birthday, the makers of his upcoming film Hari Hara ...

Kapil Kajal is an award-winning journalist with a diverse portfolio spanning defense, politics, technology, crime, environment, human rights, and foreign policy. His work has been featured in ...

Ashwini Agarwal, Founder and Partner at Demeter Advisors, expects the market "cleanup" phase to persist for some more time. However, he said the correction will offer good long-term potential in some ...